Taken together, the activated Nrf2/HO-1 pathway might attenuate the lung injury and inflammatory response in COPD by inhibiting the pyroptosis via suppressing the NLRP3/Caspase-1/GSDMD-N. Here, NFE2L2 is linked to chronic obstructive pulmonary disease.